4.4 Letter

A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist

Journal

PSYCHOPHARMACOLOGY
Volume 180, Issue 4, Pages 789-791

Publisher

SPRINGER
DOI: 10.1007/s00213-005-0060-1

Keywords

-

Funding

  1. Medical Research Council [G0400575] Funding Source: researchfish
  2. MRC [G0400575] Funding Source: UKRI
  3. Medical Research Council [G0400575] Funding Source: Medline

Ask authors/readers for more resources

The GABA-ergic system is central to many anxiety disorders and has therefore received much attention. Benzodiazepines are highly effective anxiolytics, leading to their widespread use clinically. However, benzodiazepines often have unwanted side effects, such as sedation, amnesia and ataxia, in the short term. With longer use, tolerance and dependence associated with withdrawal have led to their use being limited or discouraged (NICE 2004).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available